Efficacy of Bacillus clausii UBBC - 07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy

Maria, 2017, Radiation-induced oral mucositis, Front. Oncol., 7, 89, 10.3389/fonc.2017.00089 Köstler, 2001, Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment, CA Cancer J. Clin., 51, 290, 10.3322/canjclin.51.5.290 Pai, 2009, Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment, Annu. Rev. Pathol., 4, 49, 10.1146/annurev.pathol.4.110807.092158 Vigneswaran, 2014, Epidemiologic trends in head and neck cancer and aids in diagnosis, Oral Maxillofac. Surg. Clin., 26, 123, 10.1016/j.coms.2014.01.001 Ps, 2009, Radiation induced oral mucositis, Indian J. Palliat. Care, 15, 95, 10.4103/0973-1075.58452 Picó-Monllor, 2019, Search and selection of probiotics that improve mucositis symptoms in oncologic patients. A systematic review, Nutrients, 11, 2322, 10.3390/nu11102322 Touchefeu, 2014, Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications, Aliment. Pharmacol. Ther., 40, 409, 10.1111/apt.12878 Sharma, 2012, Lactobacillus brevis CD2 lozenges reduce radiation and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study, Eur. J. Cancer, 48, 875, 10.1016/j.ejca.2011.06.010 Jiang, 2019, A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma, Cancer, 125, 10.1002/cncr.31907 Limaye, 2013, Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy, Cancer, 119, 4268, 10.1002/cncr.28365 Plomer, 2020, Effect of Bacillus clausii capsules in reducing adverse effects associated with Helicobacter pylori eradication therapy: a randomized, double-blind, controlled trial, Infect. Dis. Ther., 9 Sudha, 2013, Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea, Benef. Microbes, 4, 211, 10.3920/BM2012.0034 Sudha, 2019, Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double-blind placebo-controlled study, Benef. Microbes, 10, 149, 10.3920/BM2018.0094 Jezewska-Frackowiak, 2018, The promises and risks of probiotic Bacillus species, Acta Biochim. Pol., 65, 509 Nista, 2004, Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial, Aliment. Pharmacol. Ther., 20, 1181, 10.1111/j.1365-2036.2004.02274.x Smiian, 2019, Optimization of the treatment of rotavirus infection in children by using Bacillus clausii, Wiad. Lek., 72, 1320, 10.36740/WLek201907117 Ahire, 2013, Comparative accounts of probiotic properties of spore and vegetative cells of Bacillus clausii UBBC07 and in silico analysis of probiotic function, Biotech, 11, 1 Lakshmi, 2017, Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic, Toxicol. Rep., 4, 62, 10.1016/j.toxrep.2016.12.004 Justino, 2014, Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice, Br. J. Nutr., 111, 1611, 10.1017/S0007114513004248 Chang, 2018, Lactobacillus casei variety Rhamnosus probiotic preventively attenuates 5-fluorouracil/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model, Front. Microbiol., 9, 983, 10.3389/fmicb.2018.00983 Justino, 2015, Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice, Cancer Chemother. Pharmacol., 75, 559, 10.1007/s00280-014-2663-x Kato, 2017, Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses, Clin. Exp. Pharmacol. Physiol., 44, 1017, 10.1111/1440-1681.12792 Tang, 2017, Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats, Nutrition, 33, 96, 10.1016/j.nut.2016.05.003 Gupta, 2020, Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis, Sci. Rep., 10, 1, 10.1038/s41598-020-73292-w Xia, 2021, A phase II randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma, Front. Immunol., 12, 545, 10.3389/fimmu.2021.618150 Davy, 2021, A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients, Support Care Cancer, 29, 2187, 10.1007/s00520-020-05548-0 2009 Rodriguez-Arrastia, 2021, Probiotic supplements on oncology patients’ treatment-related side effects: a systematic review of randomized controlled trials, Int. J. Environ. Res. Public Health, 18, 4265, 10.3390/ijerph18084265 Chattopadhyay, 2014, Role of oral glutamine in alleviation and prevention of radiation induced oral mucositis: a prospective randomized study, South Asian J. Cancer, 3, 8, 10.4103/2278-330X.126501 De Sanctis, 2019, Lactobacillus brevis CD2 for prevention of oral mucositis in patients with head and neck tumors: a multicentric randomized study, Anticancer Res., 39, 10.21873/anticanres.13303 Ghelardi, 2015, Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation, J. Appl. Microbiol., 119, 552, 10.1111/jam.12848 Liu, 2018, Probiotics in disease prevention and treatment, J. Clin. Pharmacol., 58, 10.1002/jcph.1121